synchron 40m khosla venturesparkfiercebiotech

Synchron Series Khosla Venturesparkfiercebiotech, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B

Synchron Series Khosla Venturesparkfiercebiotech CEO and Co-founder Dr. Sankai is honored worldwide for his revolutionary approach to brain-computer interfaces, which…

2 years ago

This website uses cookies.